Mr 1257 MS | CAS#61799-82-4 | Morphine antagonist

MedKoo Cat#: 598162 | Name: Mr 1257 MS

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Mr 1257 MS is a morphine antagonist.

Chemical Structure

Mr 1257 MS

CAS#61799-82-4

Theoretical Analysis

MedKoo Cat#: 598162

Name: Mr 1257 MS

CAS#: 61799-82-4

Chemical Formula: C22H29NO5S

Exact Mass: 419.1766

Molecular Weight: 419.53

Elemental Analysis: C, 62.98; H, 6.97; N, 3.34; O, 19.07; S, 7.64

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Mr 1257 MS;

IUPAC/Chemical Name

(4bR,8aR,9R)-11-(furan-3-ylmethyl)-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthren-3-ol methanesulfonate

InChi Key

BKGIERMBUHQGMY-LWBVMVAASA-N

InChi Code

InChI=1S/C21H25NO2.CH4O3S/c23-17-5-4-16-11-20-18-3-1-2-7-21(18,19(16)12-17)8-9-22(20)13-15-6-10-24-14-15;1-5(2,3)4/h4-6,10,12,14,18,20,23H,1-3,7-9,11,13H2;1H3,(H,2,3,4)/t18-,20+,21+;/m0./s1

SMILES Code

Oc1cc([C@]23[C@H]([C@H](N(Cc4cocc4)CC3)C5)CCCC2)c5cc1.O=S(O)(C)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 419.53 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC, Chen Y, Mohammad TA, Chen Y, Fedor HL, Lotan TL, Zheng Q, De Marzo AM, Isaacs JT, Isaacs WB, Nadal R, Paller CJ, Denmeade SR, Carducci MA, Eisenberger MA, Luo J. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med. 2014 Sep 11;371(11):1028-38. doi: 10.1056/NEJMoa1315815. Epub 2014 Sep 3. PubMed PMID: 25184630; PubMed Central PMCID: PMC4201502. 2: Mattam U, Jagota A. Differential role of melatonin in restoration of age-induced alterations in daily rhythms of expression of various clock genes in suprachiasmatic nucleus of male Wistar rats. Biogerontology. 2014 Jun;15(3):257-68. doi: 10.1007/s10522-014-9495-2. Epub 2014 Mar 12. PubMed PMID: 24619734. 3: Barkhof F, Bruck W, De Groot CJ, Bergers E, Hulshof S, Geurts J, Polman CH, van der Valk P. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol. 2003 Aug;60(8):1073-81. PubMed PMID: 12925362. 4: Mine T, Tanaka H, Ishida Y, Imamura R, Seki K, Taguchi T. Juvenile rheumatoid arthritis manifesting in only limping due to flexion contraction of the knee. Clin Rheumatol. 2007 Mar;26(3):433-5. Epub 2006 Jan 27. PubMed PMID: 16440136. 5: Li G, Miskimen KL, Wang Z, Xie XY, Brenzovich J, Ryan JJ, Tse W, Moriggl R, Bunting KD. STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease. Blood. 2010 Feb 18;115(7):1416-24. doi: 10.1182/blood-2009-07-234963. Epub 2009 Dec 14. PubMed PMID: 20008792; PubMed Central PMCID: PMC2826763. 6: Simões-Wüst AP, Sigrist B, Belyanskaya L, Hopkins Donaldson S, Stahel RA, Zangemeister-Wittke U. DeltaNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells. J Neurooncol. 2005 Mar;72(1):29-34. PubMed PMID: 15803372. 7: Jia D, Heersche JN. Expression of insulin-like growth factor system constituents in differentiating rat osteoblastic cell populations. Growth Horm IGF Res. 2002 Dec;12(6):399-410. PubMed PMID: 12423625.